Skip to content

A Study of Strawberries and Disease Risk

Effect of Strawberry on Oxidative Stress- and Inflammatory-mediated Insulin Resistance (IR) in Humans: Combating a Major Risk Factor for Diabetes and Cardiovascular Disease Through Diet

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01199848
Acronym
STRB
Enrollment
29
Registered
2010-09-13
Start date
2010-09-15
Completion date
2015-10-15
Last updated
2021-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation, Nutritional and Metabolic Diseases, Physiological Responses

Keywords

nutrition, polyphenolic, strawberry, insulin resistance, metabolic syndrome

Brief summary

The purpose of this study is to test whether compounds found in strawberries (polyphenolics which are typically found in berry products, tea, coffee, red wine, and chocolate) will help reduce insulin resistance and inflammation, known factors in your blood associated with disease risk, when eaten with a standard high fat/carbohydrate meal.

Detailed description

The main study is a single-center, randomized, cross-over, 4-arm, dose-response, single- blinded, 6-hour postprandial study to evaluate the ability of strawberry powder to block meal-induced oxidative stress and inflammation and concomitantly improve postprandial insulin sensitivity and glucose handling. A planned sample size of 45 will be recruited into the study. Thirty subjects for the main study and 15 subjects for the complement study. Subjects can participate in both studies and if subjects participate in both studies, there will be a time gap between the main study and the complement study due to the volume of blood permitted to collect within 56 days. The complement study will be a 2-arm placebo controlled study following the exact same protocol as the main study, but using only one strawberry dose (Dose 3 as in the main study) and comparing the effects relative to a placebo that does not control for fiber. The main study will take 5- 6 weeks per subject to complete and the complement study will take 1-2 weeks per subject to complete, depending on subject's schedule. The procedures conducted at the screening visit include blood sampling by finger prick for a fasting blood sugar test and anthropometric measurements (height, weight, and waist circumference), vital sign measurements (blood pressure and heart rate) and completion of a series of questionnaires relating to volunteers' general health and eating habits. Volunteers may be asked to complete an oral glucose/sugar tolerance test (OGTT) at screening. Volunteers will be exempt from the OGTT procedure if other qualifying conditions are present. Briefly, subjects undergoing OGTT will be asked to drink a glucose drink (similar in taste to kool-aid) in the morning after a 10 hour fast. Blood glucose finger pricks will then be done at 1 hour and 2 hours for determination of glucose tolerance. If the OGTT is necessary, additional compensation will be provided. If qualified, subjects will undergo a 7-day pre-study period during which they will be asked to record their usual diet intake for 3 days, including 2 weekdays and 1 weekend day, EITHER followed by randomization into 1 of 4 treatment beverage sequences for the main study: Placebo (Pbo), Strawberry Dose 1, Strawberry Dose 2 and Strawberry Dose 3, OR followed by randomization into 1 of 2 treatment (Placebo without fiber and Strawberry Dose 3) beverage sequences for the complement study. We expect it to be very difficult to eliminate or severely restrict polyphenolic diet during the entire study period, therefore subjects will be asked to limit only berry product intake during the study period. However, subjects will be asked to limit all polyphenolic foods in their diet for 3 days prior to each study visit. All subjects will consume the standard high fat/ carbohydrate meal (known to induce oxidative- and inflammatory- stress) accompanied by 1 of 4 test beverages (whole milk shake with or without strawberry powder) on four separate occasions for the main study OR 1 of 2 test beverages on two separate occasions for the complement study, so that each subject will serve as their own control. Subjects will arrive at the study visits fasted for at least 10 hours, well hydrated and rested. Each study visit will require blood draws throughout the visit. After pre-study procedures (height, weight, waist circumference, blood pressure, blood glucose finger prick) and while fasting, a registered nurse (RN) will place a catheter (flexible tubing) in subjects' arm for the purpose of drawing blood. This catheter will remain only throughout the study day. Approximately 1 tablespoon of blood will be taken at this time. The test meal and strawberry shake will be served and thereafter subjects will have blood draws (1 T each time) at designated time points for the next 6 hours. Each visit will last approximately 7 hours and subjects will be required to remain at the Clinical Nutrition Research Center on the IIT Campus for the duration of the visit. Blood samples will be collected at designated time points during the postprandial period for analysis of metabolic (insulin and glucose homeostasis), oxidative and inflammatory endpoint markers.

Interventions

DIETARY_SUPPLEMENTPlacebo

whole milk shake without strawberry powder served with the high fat/carbohydrate test meal

DIETARY_SUPPLEMENT10G

whole milk shake with 10g strawberry powder served with the high fat/carbohydrate test meal

DIETARY_SUPPLEMENT20G

whole milk shake with 20 strawberry powder served with the high fat/carbohydrate test meal

DIETARY_SUPPLEMENT40G

whole milk shake with 40g strawberry powder served with the high fat/carbohydrate test meal

DIETARY_SUPPLEMENTPlacebonofiber

Placebo without Fiber

Sponsors

California Strawberry Commission
CollaboratorOTHER
Clinical Nutrition Research Center, Illinois Institute of Technology
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Eligible volunteers must meet ONE or MORE of the criteria (numbers 1-4) associated with insulin resistance along with all of the other criteria listed (numbers 5-9): 1. Blood glucose concentration between140-199 mg/dL at 2hr from OGTT. 2. Elevated fasting glucose (≥110 mg/dL and \<126 mg/dL) 3. Elevated fasting insulin (\>75th percentile cutoff of 13.13 μU/mL) 4. Insulin resistance defined by the homeostasis model assessment method of insulin resistance (HOMA-IR) (glucose \[in millimoles per liter\] × insulin \[in microunits per milliliter\]/22.5) values of at least 2.5. 5. Waist circumference \>102 cm (men) and \> 88 cm (women) for screening visit invitation because many epidemiology studies have been shown that waist circumferences may be related to insulin resistance. 6. Nonsmokers 7. Not taking any medications that would interfere with outcomes of the study, i.e. lipid lowering medications, anti-inflammatory drugs, or dietary supplements 8. 18 years of age and older 9. No clinical evidence of cardiovascular, metabolic, respiratory, renal, gastrointestinal or hepatic disease

Exclusion criteria

* Pregnant and/or lactating * Allergy or intolerance to strawberries and dairy products. * Current regular consumption of strawberries is \> 2 servings per day. * Fasting blood glucose ≥ 126 mg/dL. Subjects identified with elevated fasting blood glucose levels will be advised to contact their primary care physician for appropriate follow-up care. * Taking over the counter antioxidant supplements or other supplements that may interfere with the study procedures or endpoints. * Subjects with unusual dietary habits (e.g. pica). * Actively losing weight or trying to lose weight (unstable body weight fluctuations of \> 5 kg in a 60 day period). * Excessive exercisers or trained athletes. * Subjects with documented atherosclerotic disease, inflammatory disease, diabetes mellitus, or other systemic diseases. * Addicted to drugs and/or alcohol. * Medically documented psychiatric or neurological disturbances. * Smoker (past smoker may be allowed if cessation is \> 2 years)

Design outcomes

Primary

MeasureTime frameDescription
Postprandial Insulin Levels for 6 Hours6 hour postprandial study over 4 periodsStrawberry dose-response effect on Postprandial glycemic control in insulin resistant individuals.plasma insulin concentration is measured over 6 hours by Randox clinical analyzer, analyzed with SAS mixed model.

Secondary

MeasureTime frameDescription
Strawberry Dose-response Effect on Postprandial Oxidative Stress (Ox-LDL) in Insulin-resistant Men and Women in an Acute Postprandial Paradigm6 hours postprandial study over 4 periods(treatments)Postprandial plasma Ox-LDL concentration was measured by ELISA method. Normalizing responses to subjects own baseline (Time 0) was analyzed by SAS mixed model.

Countries

United States

Participant flow

Recruitment details

The study was conducted in Chicago, IL, USA from September 2010 to January 2013.

Pre-assignment details

7-day pre-study period: Following the screening visit, qualified subjects were asked to record their usual diet intake for 3 days, including 2 weekdays and 1 weekend day in order to know their usual intake and to coach them on what foods in their diet are rich in polyphenolics, especially 3 days prior to their each study visit.

Participants by arm

ArmCount
All Participants
All participants received all 4 interventions (Placebo, STRB 10g, STRB 20g, and STRB 40g) in a randomized sequence Placebo: whole milk shake without strawberry powder served with the high fat/carbohydrate test meal Dose 1-10G: whole milk shake with 10g strawberry powder served with the high fat/carbohydrate test meal Dose 2- 20G: whole milk shake with 20 strawberry powder served with the high fat/carbohydrate test meal Dose 3-40G: whole milk shake with 40g strawberry powder served with the high fat/carbohydrate test meal
21
Total21

Baseline characteristics

CharacteristicAll Participants
Age, Continuous39.8 years
STANDARD_DEVIATION 13.8
Region of Enrollment
United States
21 Participants
Sex: Female, Male
Female
16 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 210 / 210 / 210 / 21
other
Total, other adverse events
0 / 210 / 210 / 210 / 21
serious
Total, serious adverse events
0 / 210 / 210 / 210 / 21

Outcome results

Primary

Postprandial Insulin Levels for 6 Hours

Strawberry dose-response effect on Postprandial glycemic control in insulin resistant individuals.plasma insulin concentration is measured over 6 hours by Randox clinical analyzer, analyzed with SAS mixed model.

Time frame: 6 hour postprandial study over 4 periods

Population: study completer who finished all 4 treatments.

ArmMeasureValue (MEAN)Dispersion
PlaceboPostprandial Insulin Levels for 6 Hours63.9 microIU/mLStandard Error 5.6
10G STRB PowderPostprandial Insulin Levels for 6 Hours64.3 microIU/mLStandard Error 5.6
20G STRB PowderPostprandial Insulin Levels for 6 Hours60.2 microIU/mLStandard Error 5.6
40G STRB PowderPostprandial Insulin Levels for 6 Hours56.3 microIU/mLStandard Error 5.6
Secondary

Strawberry Dose-response Effect on Postprandial Oxidative Stress (Ox-LDL) in Insulin-resistant Men and Women in an Acute Postprandial Paradigm

Postprandial plasma Ox-LDL concentration was measured by ELISA method. Normalizing responses to subjects own baseline (Time 0) was analyzed by SAS mixed model.

Time frame: 6 hours postprandial study over 4 periods(treatments)

ArmMeasureValue (MEAN)Dispersion
PlaceboStrawberry Dose-response Effect on Postprandial Oxidative Stress (Ox-LDL) in Insulin-resistant Men and Women in an Acute Postprandial Paradigm-0.1 U/LStandard Error 0.8
10G STRB PowderStrawberry Dose-response Effect on Postprandial Oxidative Stress (Ox-LDL) in Insulin-resistant Men and Women in an Acute Postprandial Paradigm-0.3 U/LStandard Error 0.8
20G STRB PowderStrawberry Dose-response Effect on Postprandial Oxidative Stress (Ox-LDL) in Insulin-resistant Men and Women in an Acute Postprandial Paradigm-3 U/LStandard Error 0.8
40G STRB PowderStrawberry Dose-response Effect on Postprandial Oxidative Stress (Ox-LDL) in Insulin-resistant Men and Women in an Acute Postprandial Paradigm-0.17 U/LStandard Error 0.8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026